logoalt Hacker News

tptacekyesterday at 10:46 PM3 repliesview on HN

It is wild that it took until 2026 for this to happen.

In the late 1990s, when my friends wanted mushrooms or 5MEO-DMT, they'd order from "Poisonous Non-Consumables" catalogs. Today, people are literally doing that (same words, even!), but for the next iteration of GLP1 drugs not yet on the wider market. Compounding pharmacies are selling "research chemicals", like in Bitcoin Mining Profit Calculator: Gaiden.


Replies

rootusrootustoday at 1:40 AM

Compounding pharmacies are selling compound, not "for research only" peptides. That's a different thing, even if they probably get the API (drug itself) from the same sources.

loegyesterday at 10:49 PM

I think this is compounding pharmacies selling legit semaglutide (or tirzepatide?), but doing the packaging (dilution in water) themselves. No? I don't think Hims is selling RCs. They're violating Novo's (or Lilly's) patents.

It is wild to me that compounding pharmacies continued to sell these in violation of patents even after the expiration of the FDA supply shortfall status last year -- but I suppose there's so much money in it they don't want to give it up.

https://www.fda.gov/drugs/drug-safety-and-availability/fda-c...

show 2 replies
cjyesterday at 10:48 PM

People are getting retatrutide from random websites (not what’s being shut down here) not from compounding pharmacies.

show 1 reply